4-Demethoxydaunorubicin (idarubicin) in relapsed and refractory acute myeloid leukemia.
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015255:Idarubicin; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male
D000903:Antibiotics, Antineoplastic; D003561:Cytarabine; D005047:Etoposide; D015255:Idarubicin; D003630:Daunorubicin